Paragon Associates & Paragon Associates II Joint Venture’s Reata Pharmaceuticals, Inc. Class A Common Stock RETA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
|
|||||
|
2021
Q3 | $4.69M | Sell |
|
|||||
|
2021
Q2 | $9.64M | Sell |
|
|||||
|
2021
Q1 | $9.97M | Sell |
|
|||||
|
2020
Q4 | $17.3M | Sell |
|
|||||
|
2020
Q3 | $14.6M | Sell |
|
|||||
|
2020
Q2 | $31.4M | Sell |
|
|||||
|
2020
Q1 | $29.4M | Sell |
|
|||||
|
2019
Q4 | $45.4M | Sell |
|
|||||
|
2019
Q3 | $19.7M | Hold |
|
|||||
|
2019
Q2 | $23.1M | Hold |
|
|||||
|
2019
Q1 | $20.9M | Hold |
|
|||||
|
2018
Q4 | $13.7M | Buy |
|
|||||
|
2018
Q3 | $19.6M | Sell |
|
|||||
|
2018
Q2 | $8.74M | Hold |
|
|||||
|
2018
Q1 | $5.13M | Hold |
|
|||||
|
2017
Q4 | $7.08M | Hold |
|
|||||
|
2017
Q3 | $7.78M | Hold |
|
|||||
|
2017
Q2 | $7.91M | Hold |
|
|||||
|
2017
Q1 | $5.66M | Hold |
|
|||||
|
2016
Q4 | $5.46M | Buy |
|
|||||
|
2016
Q3 | $3.95M | Hold |
|
|||||
|
2016
Q2 | $2.96M | Buy |
|